Embla Medical hf.
EMBLA
Rank in Stocks
#6358
Embla Medical hf., together with its subsidiaries, provides non-invasive... Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. The Bracing and Supports segment provides osteoarthritis solutions that are designed to reduce pain and improve mobility for people living with osteoarthritis; and injury solutions for people recovering from fractures, ligament injuries, or need post-operative treatment. This segment also offers Unloader One, a range knee braces that relieve pain from knee osteoarthritis; and Unloader Hip, which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip. The Patient Care segment provides prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions. The company serves orthopedic and prosthetic clinics, hospitals, and surgery centers. It sells its products through its direct sales networks and distributors. The company was formerly known as Γssur hf. and changed its name to Embla Medical hf. in April 2024. Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S.
Share Price
$4.14
Last synced: 2026-11-12
Market Cap
$1.76B
Change (1 day)
-1.38%
Change (1 year)
-21.78%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Embla Medical hf. (EMBLA)
Category
Healthcare
EPS for Embla Medical hf. (EMBLA)
EPS as of September 2026 TTM: $0.22
According to Embla Medical hf.'s latest financial reports, its current EPS (TTM) is $0.22. At the end of 2025 the company had an EPS of $0.20, an increase over its 2024 EPS of $0.16.
EPS history for Embla Medical hf. from 2002 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.22 | 10.00% |
| 2025 | $0.20 | 25.00% |
| 2024 | $0.16 | 14.29% |
| 2023 | $0.14 | 40.00% |
| 2022 | $0.10 | -33.33% |
| 2021 | $0.15 | 920.41% |
| 2020 | $0.01 | -90.81% |
| 2019 | $0.16 | -15.79% |
| 2018 | $0.19 | 46.15% |
| 2017 | $0.13 | 8.33% |
| 2016 | $0.12 | 0.00% |
| 2015 | $0.12 | -7.69% |
| 2014 | $0.13 | 44.44% |
| 2013 | $0.09 | 5.02% |
| 2012 | $0.09 | 11.30% |
| 2011 | $0.08 | -1.16% |
| 2010 | $0.08 | 46.43% |
| 2009 | $0.05 | -21.07% |
| 2008 | $0.07 | 247.42% |
| 2007 | $0.02 | 71.68% |
| 2006 | $0.01 | -67.99% |
| 2005 | $0.04 | -26.46% |
| 2004 | $0.05 | 231.03% |
| 2003 | $0.01 | -53.53% |
| 2002 | $0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | 1,127.27% |
US
|
|
| $4.09 | 1,759.09% |
IE
|
|
| $9.45 | 4,195.45% |
US
|
|
| $2.37 | 977.27% |
US
|
|
| $1.77 | 704.55% |
US
|
Questions about Embla Medical hf.'s earnings per share (EPS)
What is Embla Medical hf.'s earnings per share (EPS)?
Embla Medical hf.'s earnings per share (EPS) over the last twelve months is $0.22, as of Sep 2026.
What was Embla Medical hf.'s earnings per share (EPS) in 2025?
In 2025, Embla Medical hf.'s earnings per share (EPS) was $0.20, 25.00% more than in 2024 ($0.16).
How has Embla Medical hf.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Embla Medical hf.'s earnings per share (EPS) went from $0.01 to $0.20, an average growth of 82.06% a year.
How does Embla Medical hf.'s earnings per share (EPS) compare with similar companies?
Embla Medical hf.'s earnings per share (EPS) ($0.22) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.